Linked from

The 9 pages that link to Merck & Co., each with the reason it gives.

• Eli Lilly and CompanyCompared with: Its scale and research portfolio provide a close comparison with Lilly’s pharmaceutical business.

• Bristol Myers SquibbCompared with: Merck competes with Bristol Myers Squibb in oncology and immune-checkpoint therapy.

• MolnupiravirRelated: Merck co-developed molnupiravir with Ridgeback and conducted large clinical trials.

• William C. CampbellRelated: Campbell conducted the drug-discovery research at Merck’s laboratories.

• SitagliptinRelated: The company advanced sitagliptin from incretin research into clinical use.

• Johnson & JohnsonCompared with: It competes with Johnson & Johnson in medicines and oncology treatments.

• NovartisCompared with: Its research-led business offers another comparison with Novartis’s strategy.

• SimvastatinRelated: Merck developed simvastatin from earlier statin research and brought it to clinical use.

• IndometacinRelated: The company developed indometacin, which entered clinical use in the 1960s.